Skip to main content
. 2022 Nov-Dec;114-115:6–17. doi: 10.1016/j.nucmedbio.2022.08.006

Fig. 1.

Fig. 1

A) Chemical structures of the SOD mimetic Mn(III) porphyrins in clinical trials: BMX-001 (top) and BMX-010 (mid); and the cell/liposome radiolabelling agent [52Mn]Mn-oxine. B) Chemical structures of the porphyrins and their respective 52Mn complexes used in this work.